Found: 23
Select item for more details and to access through your institution.
Rekombinowana adjuwantowa szczepionka przeciwko półpaścowi zmniejsza ból związany z półpaścem oraz redukuje stosowanie leków przeciwbólowych w trzech randomizowanych kontrolowanych placebo badaniach.
- Published in:
- Pain Research / Ból, 2023, v. 24, n. 2, p. 22, doi. 10.5604/01.3001.0053.7735
- By:
- Publication type:
- Article
Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association Between Hemagglutination Inhibition Antibody Titers and Protection Against Reverse-Transcription Polymerase Chain Reaction–Confirmed Influenza Illness in Children 6–35 Months of Age: Statistical Evaluation of a Correlate of Protection
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 2, p. 1, doi. 10.1093/ofid/ofab477
- By:
- Publication type:
- Article
2905. Long-term Immunological Persistence of the Adjuvanted Recombinant Zoster Vaccine: Clinical Data and Mathematical Modeling.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S84, doi. 10.1093/ofid/ofz359.183
- By:
- Publication type:
- Article
2779. Efficacy of the Adjuvanted Recombinant Zoster Vaccine According to Sex, Geographic Region, and Geographic Ancestry/Ethnicity: A Post-hoc Analysis.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S981, doi. 10.1093/ofid/ofz360.2456
- By:
- Publication type:
- Article
2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S981, doi. 10.1093/ofid/ofz360.2457
- By:
- Publication type:
- Article
2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S980, doi. 10.1093/ofid/ofz360.2455
- By:
- Publication type:
- Article
2319. Clinical Predictors of Influenza and Hospitalization of Children with Influenza in an Emergent Care Setting.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S795, doi. 10.1093/ofid/ofz360.1997
- By:
- Publication type:
- Article
Evaluation of a New Clinical Endpoint for Moderate to Severe Influenza Disease in Children: A Prospective Cohort Study.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 4, p. 460, doi. 10.1093/jpids/piz075
- By:
- Publication type:
- Article
Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study.
- Published in:
- Vaccines, 2023, v. 11, n. 6, p. 1058, doi. 10.3390/vaccines11061058
- By:
- Publication type:
- Article
Acellular Pertussis Vaccines: The Rationale For An Efficacy Trial In Germany.
- Published in:
- Journal of Infectious Diseases, 1996, v. 174, n. Supplement_3, p. S287
- By:
- Publication type:
- Article
Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The Interplay Between Host Genetic Variation, Viral Replication, and Microbial Translocation in Untreated HIV-Infected Individuals.
- Published in:
- Journal of Infectious Diseases, 2015, v. 212, n. 4, p. 578, doi. 10.1093/infdis/jiv089
- By:
- Publication type:
- Article
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.
- Published in:
- Rheumatology, 2021, v. 60, n. 3, p. 1226, doi. 10.1093/rheumatology/keaa424
- By:
- Publication type:
- Article
Intestinal imaging of children with acute rotavirus gastroenteritis.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system.
- Published in:
- Influenza & Other Respiratory Viruses, 2021, v. 15, n. 1, p. 110, doi. 10.1111/irv.12780
- By:
- Publication type:
- Article
Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.
- Published in:
- Journal of the American Geriatrics Society, 2021, v. 69, n. 3, p. 744, doi. 10.1111/jgs.16917
- By:
- Publication type:
- Article
Immunogenicity of the Adjuvanted Recombinant Zoster Vaccine: Persistence and Anamnestic Response to Additional Doses Administered 10 Years After Primary Vaccination.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study.
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-10283-3
- By:
- Publication type:
- Article